StockNews.AI
KWR
StockNews.AI
176 days

QUAKER HOUGHTON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS

1. Q4 net sales fell 5% year-over-year due to lower selling prices and mix. Declining organic volumes and unfavorable currency impacted results. 2. GAAP net income dropped from $20.2M to $14.2M, with non‐GAAP metrics also down. Operating margins and adjusted EBITDA were similarly pressured. 3. Strong operating cash flow of $204.6M and shareholder returns of ~$82M were achieved. Strategic acquisitions and share repurchases supported liquidity. 4. CEO highlighted a $20M cost savings initiative in 2025 to improve competitiveness. New business wins, especially in Asia/Pacific, partially offset soft markets.

+2.61%Current Return
VS
-0.5%S&P 500
$140.7402/24 04:35 PM EDTEvent Start

$144.4102/25 10:46 PM EDTLatest Updated
48m saved
Insight
Article

FAQ

Why Neutral?

The Q4 results showed muted earnings and revenue declines which mirror historical cyclical weakness in the chemical sector. Despite lower immediate earnings, strong cash flows and cost-saving initiatives suggest that investors may view the current environment as a temporary challenge.

How important is it?

While short-term earnings were under pressure, the company’s strong cash flow, strategic acquisitions, and cost-saving actions point to a meaningful long-term turnaround potential that investors should monitor.

Why Long Term?

The planned cost reduction and strategic repositioning indicate potential improvements in operational efficiency over time. Past instances in industrial chemicals have shown that sustained margin enhancements can support longer-term valuation gains.

Related Companies

Q4'24 net sales of $444.1 million, net income of $14.2 million and earnings per diluted share of $0.81 Q4'24 non-GAAP net income of $23.6 million and non-GAAP earnings per diluted share of $1.33 Full year net sales of $1.84 billion, net income of $116.6 million and earnings per diluted share of $6.51 Full year non-GAAP net income of $133.5 million and non-GAAP earnings per diluted share of $7.44 Delivered Q4'24 and full year adjusted EBITDA of $64.8 million and $310.9 million, respectively Generated operating cash flow of $204.6 million in 2024; completed two strategic acquisitions; and returned $82.4 million to shareholders through dividends and share repurchases , /PRNewswire/ -- Quaker Houghton ("the Company") (NYSE: KWR), the global leader in industrial process fluids, announced its fourth quarter and full year 2024 results today. Three Months EndedDecember 31, Twelve Months EndedDecember 31, ($ in thousands, except per share data) 2024 2023 2024 2023 Net sales $         444,086 $         467,109 $      1,839,686 $      1,953,313 Net income attributable to Quaker Chemical Corporation 14,186 20,198 116,644 112,748 Net income attributable to Quaker Chemical Corporation common shareholders – diluted 0.81 1.12 6.51 6.26 Non-GAAP net income * 23,570 31,949 133,456 137,643 Non-GAAP earnings per diluted share * 1.33 1.78 7.44 7.65 Adjusted EBITDA * 64,783 76,964 310,918 320,379 *   Refer to the Non-GAAP Measures and Reconciliations section below for additional information. Fourth Quarter 2024 Consolidated Results Net sales in the fourth quarter of 2024 were $444.1 million, a decrease of 5% compared to $467.1 million in the fourth quarter of 2023. This result was due to a decrease in selling price and product mix of approximately 4%, an unfavorable impact from foreign currency translation of 2%, and a decline in organic sales volumes of approximately 1%, partially offset by 2% increase in sales from acquisitions. Selling price and product mix declined due to the impact of index-based customer contracts and mix of products and services whereas the decline in organic sales volumes reflect a continuation of soft end market conditions, partially offset by new business wins in all segments. The Company reported net income in the fourth quarter of 2024 of $14.2 million, or $0.81 per diluted share, compared to $20.2 million or $1.12 per diluted share in the fourth quarter of 2023. As described in further detail in the Non-GAAP section below, excluding non-recurring and non-core items in each period, the Company's fourth quarter of 2024 non-GAAP net income and earnings per diluted share were $23.6 million and $1.33 respectively compared to $31.9 million and $1.78 respectively in the prior year period. The Company generated adjusted EBITDA of $64.8 million in the fourth quarter of 2024, a decrease of approximately 16% compared to $77.0 million in the fourth quarter of 2023, primarily driven by the decline in sales and operating margins. Joseph A. Berquist, Chief Executive Officer and President, commented, "In 2024, Quaker Houghton improved its profitability and generated strong cash flow, while managing through a challenging macro environment.  New business wins across all regions, and especially Asia/Pacific, helped mitigate the impact of lower end market demand, primarily in the Americas and EMEA segments.  Our business model and balance sheet are strong, and in 2024 we returned approximately $80 million to shareholders through dividends and share repurchases while also investing for growth.  I want to thank our Quaker Houghton employees for their dedication to our customers and their committed execution on our strategic initiatives." "Looking ahead, our priorities are to deliver sustained growth and share gains by advancing our enterprise strategy, refocusing the organization around our unique customer intimate model and effectively allocating capital.  We are taking additional steps to reduce complexity which are expected to deliver run-rate cost savings of at least $20 million in 2025.  We anticipate these actions will enhance our operational efficiency, improve our competitiveness, and better leverage our global scale.  Executing on our strategic initiatives will enable us to begin to unlock Quaker Houghton's full potential and we expect to deliver revenue, adjusted EBITDA and earnings growth in 2025." Fourth Quarter and Full Year 2024 Segment Results The Company's fourth quarter and full year 2024 operating performance of each of its three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific are further described below. Three Months EndedDecember 31, Twelve Months EndedDecember 31, 2024 2023 2024 2023 Net Sales * Americas $         208,585 $         226,564 $         882,131 $         977,095 EMEA 125,877 135,745 536,435 571,347 Asia/Pacific 109,624 104,800 421,120 404,871 Total net sales $         444,086 $         467,109 $      1,839,686 $      1,953,313 Segment operating earnings * Americas $           50,930 $           61,756 $         243,957 $         266,036 EMEA 18,559 23,735 99,426 104,811 Asia/Pacific 30,705 31,854 122,738 118,458 Total segment operating earnings $         100,194 $         117,345 $         466,121 $         489,305 *   Refer to the Segment Measures and Reconciliations section below for additional information. The following table summarizes the sales variances by reportable segment and consolidated operations in the fourth quarter of 2024 compared to the fourth quarter of 2023: Sales volumes Selling price & product mix Foreign currency Acquisition & other Total Americas (1) % (3) % (4) % — % (8) % EMEA (7) % (3) % — % 3 % (7) % Asia/Pacific 5 % (3) % — % 3 % 5 % Consolidated (1) % (4) % (2) % 2 % (5) % Net sales in the Americas segment declined in the fourth quarter of 2024 compared to same quarter in 2023 primarily as a result of a decline in selling price and product mix, an unfavorable impact of foreign currency translation and a modest decline in sales volumes.  Net sales in the EMEA segment declined in the fourth quarter of 2024 compared to same quarter in 2023 due to a decline in organic sales volumes and a decline in selling price and product mix, partially offset by the contribution from the acquisition of I.K.V. Tribologie IKVT ("IKV"). Net sales in the Asia/Pacific segment increased in the fourth quarter of 2024 compared to same quarter in 2023 due to an increase in sales volumes and a contribution from the acquisition of the Sutai Group ("Sutai"), partially offset by a decline in selling price and product mix. The decline in selling price and product mix in the fourth quarter of 2024 compared to the prior year period reflects the impact of our index-based customer contracts as well as mix of products and services. Sales volumes increased in the Asia/Pacific segment primarily due to continued new business wins and a modest improvement in demand. Volumes declined in the Americas and EMEA segments in the fourth quarter of 2024 compared to the prior year period primarily due to weaker end market conditions, partially offset by new business wins. Compared to the third quarter of 2024, total company sales decreased approximately 4% due to a decline in selling price and product mix of 2%, a decline in sales volumes of 1% and an unfavorable impact of foreign currency translation of 1%. Net sales, sales volumes and selling price and product mix all declined in the Americas and EMEA segments, due to normal seasonal trends and a further softening of market conditions, but increased in the Asia/Pacific segment. All segments had an unfavorable impact from foreign currency translation in the fourth quarter compared to the third quarter of 2024. Operating earnings and operating margins declined in all three segments in the fourth quarter of 2024 compared to the prior year period. For the full year 2024, operating earnings increased in the Asia/Pacific segment and declined in Americas and EMEA segments compared to the prior year. Operating margins increased in Americas and EMEA segments and declined slightly in the Asia/Pacific segment in the full year 2024 compared to the prior year. Cash Flow and Liquidity Highlights Net cash provided by operating activities was $204.6 million for the year ended December 31, 2024, compared to net cash provided by operating activities of $279.0 million for the year ended December 31, 2023. The higher operating cash flow in the prior year was primarily a result of a higher inflow of working capital as the company reduced its inventory levels. As of December 31, 2024, the Company's total gross debt was $708.3 million and its cash and cash equivalents was $188.9 million, which resulted in net debt of $519.4 million. The Company's net debt divided by its trailing twelve months adjusted EBITDA was approximately 1.7x. In the fourth quarter of 2024, the Company repurchased 174,909 shares for approximately $26.3 million. In the full year of 2024, the Company repurchased 312,997 shares for approximately $49.2 million. In 2024, the Company returned approximately $82.4 million to shareholders through dividends and share repurchases. Non-GAAP Measures and Reconciliations The information in this press release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, facilitate a comparison among fiscal periods, and exclude items that management believes are not indicative of future operating performance or core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. In addition, our definitions of EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income, and non-GAAP earnings per share, as discussed and reconciled below to the most comparable GAAP measures, may not be comparable to similarly named measures reported by other companies. The Company presents EBITDA which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies. The Company also presents adjusted EBITDA, which is calculated as EBITDA plus or minus certain items that management believes are not indicative of future operating performance or not considered core to the Company's operations. In addition, the Company presents non-GAAP operating income which is calculated as operating income plus or minus certain items that management believes are not indicative of future operating performance or considers core to the Company's operations. Adjusted EBITDA margin and non-GAAP operating margin are calculated as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the operating performance of the Company on a consistent basis. Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the "two-class share method." The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the performance of the Company on a consistent basis. As it relates to future projections for the Company as well as other forward-looking information contained in this press release, the Company has not provided guidance for comparable GAAP measures or a quantitative reconciliation of forward-looking non-GAAP financial measures to the most directly comparable U.S. GAAP measure because it is unable to determine with reasonable certainty the ultimate outcome of certain significant items necessary to calculate such measures without unreasonable effort. These items include, but are not limited to, certain non-recurring or non-core items the Company may record that could materially impact net income. These items are uncertain, depend on various factors, and could have a material impact on the U.S. GAAP reported results for the guidance period. The Company's reference to trailing twelve months adjusted EBITDA within this press release refers to the twelve month period ended December 31, 2024 adjusted EBITDA of $310.9 million, as presented in the non-GAAP reconciliations below. Certain of the prior period non-GAAP financial measures presented in the following tables have been adjusted to conform with current period presentation. The following tables reconcile the Company's non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts): Three Months EndedDecember 31, Twelve Months EndedDecember 31, Non-GAAP Operating Income and Margin Reconciliations: 2024 2023 2024 2023 Operating income $        29,013 $        48,253 $      194,706 $      214,495 Acquisition-related expenses 956 — 1,854 — Restructuring and related charges, net 1,743 1,554 6,530 7,588 Strategic planning expenses (credits) — 945 (290) 4,704 Executive transition costs 6,556 — 7,288 688 Customer insolvency costs 1,691 — 3,213 — Other charges 494 132 399 299 Non-GAAP operating income $        40,453 $        50,884 $      213,700 $      227,774 Non-GAAP operating margin (%) 9.1 % 10.9 % 11.6 % 11.7 % EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Non-GAAP Net Income Reconciliations: Three Months EndedDecember 31, Twelve Months EndedDecember 31, 2024 2023 2024 2023 Net income attributable to Quaker Chemical Corporation $        14,186 $        20,198 $      116,644 $      112,748 Depreciation and amortization (a) 21,201 20,809 85,108 83,020 Interest expense, net 9,077 11,955 41,002 50,699 Taxes on income before equity in net income of associated companies (b) 8,847 18,629 49,300 55,585 EBITDA 53,311 71,591 292,054 302,052 Equity income in a captive insurance company (1,664) (1,342) (2,930) (2,090) Acquisition-related expenses (credits) 956 — 1,454 (475) Restructuring and related charges, net 1,743 1,554 6,530 7,588 Strategic planning expenses (credits) — 945 (290) 4,704 Executive transition costs 6,556 — 7,288 688 Customer insolvency costs 1,691 — 3,213 — Facility remediation recoveries, net — (1,127) — (2,141) Product liability claim costs, net 1,144 — 2,040 — Business interruption insurance proceeds — — (1,000) — Currency conversion impacts of hyper-inflationary economies 478 4,980 811 7,849 Other charges 568 363 1,748 2,204 Adjusted EBITDA $        64,783 $        76,964 $      310,918 $      320,379 Adjusted EBITDA margin (%) 14.6 % 16.5 % 16.9 % 16.4 % Adjusted EBITDA $        64,783 $        76,964 $      310,918 $      320,379 Less: Depreciation and amortization – adjusted (a) 21,201 20,809 85,108 83,020 Less: Interest expense, net 9,077 11,955 41,002 50,699 Less: Taxes on income before equity in net income of associated companies – adjusted (b) 10,935 12,251 51,352 49,017 Non-GAAP net income $        23,570 $        31,949 $      133,456 $      137,643 Three Months EndedDecember 31, Twelve Months EndedDecember 31, Non-GAAP Earnings per Diluted Share Reconciliations: 2024 2023 2024 2023 GAAP earnings per diluted share attributable to Quaker Chemical  Corporation common shareholders $                0.81 $                1.12 $                6.51 $                6.26 Equity income in a captive insurance company per diluted share (0.09) (0.08) (0.16) (0.12) Acquisition-related expenses (credits) 0.04 — 0.06 (0.03) Restructuring and related charges, net per diluted share 0.08 0.07 0.28 0.32 Strategic planning expenses (credits) per diluted share — 0.04 (0.01) 0.21 Executive transition costs per diluted share 0.28 — 0.31 0.03 Customer insolvency costs per diluted share 0.07 — 0.13 — Facility remediation recoveries, net per diluted share — (0.04) — (0.09) Product liability claim costs, net per diluted share 0.05 — 0.09 — Business interruption insurance proceeds per diluted share — — (0.04) — Currency conversion impacts of hyper-inflationary economies per diluted share 0.03 0.28 0.05 0.44 Other charges per diluted share — 0.01 0.05 0.09 Impact of certain discrete tax items per diluted share (c) 0.06 0.38 0.17 0.54 Non-GAAP earnings per diluted share $                1.33 $                1.78 $                7.44 $                7.65 (a)      Depreciation and amortization for the years ended December 31, 2024 and 2023 each includes $1.0 million of amortization expense recorded within equity in net income of associated companies in the Company's Consolidated Statements of Operations, which is attributable to the amortization of the fair value step up for the Company's 50% interest in a joint venture in Korea as a result of required purchase accounting. (b)      Taxes on income before equity in net income of associated companies – adjusted includes the Company's tax expense adjusted for the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of Net income attributable to Quaker Chemical Corporation to adjusted EBITDA, above, determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility. This caption also includes the impact of specific tax charges and benefits for the year ended December 31, 2024 and 2023. (c)    The impacts of certain discrete tax items include certain impacts of tax law changes, valuation allowance adjustments, uncertain tax positions, provision to return and other adjustments, and the impact on certain intercompany asset transfers. For the year ended December 31, 2023, the impacts also included $6.7 million of withholding taxes for the repatriation of non-U.S. earnings. Segment Measures and Reconciliations Segment operating earnings for each of the Company's reportable segments are comprised of the segment's net sales less directly related product costs and other operating expenses. Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs and restructuring charges, are not included in segment operating earnings. Other items not specifically identified with the Company's reportable segments include Interest expense, net and Other (expense) income, net. The following table presents information about the performance of the Company's reportable segments (dollars in thousands): Three Months EndedDecember 31, Twelve Months EndedDecember 31, 2024 2023 2024 2023 Net Sales Americas $         208,585 $         226,564 $         882,131 $         977,095 EMEA 125,877 135,745 536,435 571,347 Asia/Pacific 109,624 104,800 421,120 404,871 Total net sales $         444,086 $         467,109 $      1,839,686 $      1,953,313 Segment operating earnings Americas $           50,930 $           61,756 $         243,957 $         266,036 EMEA 18,559 23,735 99,426 104,811 Asia/Pacific 30,705 31,854 122,738 118,458 Total segment operating earnings 100,194 117,345 466,121 489,305 Restructuring and related charges, net (1,743) (1,554) (6,530) (7,588) Non-operating and administrative expenses (54,418) (52,397) (203,956) (206,398) Depreciation of corporate assets and amortization (15,020) (15,141) (60,929) (60,824) Operating income 29,013 48,253 194,706 214,495 Other (expense) income, net (931) (2,114) 1,354 (10,672) Interest expense, net (9,077) (11,955) (41,002) (50,699) Income before taxes and equity in net income of associated companies $           19,005 $           34,184 $         155,058 $         153,124 Forward-Looking Statements This press release contains "forward-looking statements" that fall under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and the Securities Act of 1933, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on assumptions, projections and expectations about future events that we believe are reasonable based on currently available information, including statements regarding the potential effects of economic downturns; tariffs, including uncertainty surrounding changes in tariffs; inflation and global supply chain constraints on the Company's business, results of operations, and financial condition; our expectation that we will maintain sufficient liquidity and remain in compliance with the terms of the Company's credit facility; expectations about future demand and raw material costs; and statements regarding the impact of increased raw material costs and pricing initiatives. These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance, and business, which may differ materially from our actual results, including but not limited to the potential benefits of acquisitions and divestitures, the impacts on our business as a result of global supply chain constraints, and our current and future results and plans and statements that include the words "may," "could," "should," "would," "believe," "expect," "anticipate," "estimate," "intend," "outlook, "target", "possible", "potential", "plan" or similar expressions. Such statements include information relating to current and future business activities, operational matters, capital spending, and financing sources. A major risk is that demand for the Company's products and services is largely derived from the demand for its customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production slowdowns and shutdowns. Other major risks and uncertainties include, but are not limited to inflationary pressures, including increases in raw material costs; supply chain constraints and the impacts of economic downturns; customer financial instability; high interest rates and their impact on our and our customers' business operations; the impacts from acts of war, terrorism and military conflicts, including those in Ukraine and the Middle East as well as economic, political and governmental actions taken by various governments and governmental organizations in response; economic and political disruptions particularly in light of numerous elections globally and the possibility of regime changes; the possibility of economic recession; legislative and regulatory developments including changes to existing laws and regulations, or the way they are interpreted, applied or enforced; tariffs, trade restrictions, and the economic and other sanctions imposed by other nations on Russia and Belarus and/or other government organizations; suspensions of activities in Russia by many multinational companies; foreign currency fluctuations; significant changes in applicable tax rates and regulations; future terrorist attacks and other acts of violence; the impacts of consolidation in our industry, including loss or consolidation of a major customer, the effects of climate change, fires, or other natural disasters; and the potential occurrence of cyber-security breaches, cyber-security attacks and other technology outages and security incidents. Furthermore, the Company is subject to the same business cycles as those experienced by our customers in the steel, automobile, aircraft, industrial equipment, aluminum and durable goods industries. Our forward-looking statements are subject to risks, uncertainties and assumptions about the Company and its operations that are subject to change based on various important factors, some of which are beyond our control. These risks, uncertainties, and possible inaccurate assumptions relevant to our business could cause our actual results to differ materially from expected and historical results. All forward-looking statements included in this press release, including expectations about business conditions during 2024 and future periods, are based upon information available to the Company as of the date of this press release, which may change. Therefore, we caution you not to place undue reliance on our forward-looking statements. For more information regarding these risks and uncertainties as well as certain additional risks that we face, refer to the Risk Factors section, which appears in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024, and in subsequent reports filed from time to time with the Securities and Exchange Commission. We do not intend to, and we disclaim any duty or obligation to, update or revise any forward-looking statements to reflect new information or future events or for any other reason. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995. Conference Call As previously announced, the Company's investor conference call to discuss its fourth quarter and full year 2024 performance is scheduled for Tuesday, February 25, 2025 at 8:30 a.m. ET. A live webcast of the conference call, together with supplemental information, can be accessed through the Company's Investor Relations website at investors.quakerhoughton.com. You can also access the conference call by dialing 877-269-7756. About Quaker Houghton Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, our customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, can, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge and customized services. With approximately 4,400 employees, including chemists, engineers and industry experts, we partner with our customers to improve their operations so they can run even more efficiently, even more effectively, whatever comes next. Quaker Houghton is headquartered in Conshohocken, Pennsylvania, located near Philadelphia in the United States. Visit quakerhoughton.com to learn more. QUAKER CHEMICAL CORPORATIONCONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited; Dollars in thousands, except per share data) Three Months EndedDecember 31, Twelve Months EndedDecember 31, 2024 2023 2024 2023 Net sales $         444,086 $         467,109 $      1,839,686 $      1,953,313 Cost of goods sold 287,886 295,953 1,153,656 1,247,669 Gross profit 156,200 171,156 686,030 705,644 Selling, general and administrative expenses 125,444 121,349 484,794 483,561 Restructuring and related charges, net 1,743 1,554 6,530 7,588 Operating income 29,013 48,253 194,706 214,495 Other (expense) income, net (931) (2,114) 1,354 (10,672) Interest expense, net (9,077) (11,955) (41,002) (50,699) Income before taxes and equity in net income of associated companies 19,005 34,184 155,058 153,124 Taxes on income before equity in net income of associated companies 8,847 18,629 49,300 55,585 Income before equity in net income of associated companies 10,158 15,555 105,758 97,539 Equity in net income of associated companies 4,031 4,673 10,971 15,333 Net income 14,189 20,228 116,729 112,872 Less: Net income attributable to noncontrolling interest 3 30 85 124 Net income attributable to Quaker Chemical Corporation $           14,186 $           20,198 $         116,644 $         112,748 Per share data: Net income attributable to Quaker Chemical Corporation common shareholders – basic $                0.80 $                1.12 $                6.51 $                6.27 Net income attributable to Quaker Chemical Corporation common shareholders – diluted $                0.81 $                1.12 $                6.51 $                6.26 Basic weighted average common shares outstanding 17,735,186 17,901,225 17,850,462 17,892,461 Diluted weighted average common shares outstanding 17,765,771 17,921,070 17,870,067 17,914,809 QUAKER CHEMICAL CORPORATION CONSOLIDATED BALANCE SHEETS (Unaudited; Dollars in thousands, except par value) December 31, 2024 2023 ASSETS Current assets Cash and cash equivalents $         188,880 $         194,527 Accounts receivable, net 400,126 444,950 Inventories 227,472 233,857 Prepaid expenses and other current assets 59,939 54,555 Total current assets 876,417 927,889 Property, plant and equipment, net 229,532 207,811 Right-of-use lease assets 34,120 38,614 Goodwill 518,894 512,518 Other intangible assets, net 827,098 896,721 Investments in associated companies 98,012 101,151 Deferred tax assets 9,216 10,737 Other non-current assets 17,360 18,770 Total assets $      2,610,649 $      2,714,211 LIABILITIES AND EQUITY Current liabilities Short-term borrowings and current portion of long-term debt $           37,554 $           23,444 Accounts payable 198,137 184,813 Dividends payable 8,572 8,186 Accrued compensation 50,212 55,194 Accrued restructuring 2,297 3,350 Accrued pension and postretirement benefits 2,328 2,208 Other accrued liabilities 80,668 90,315 Total current liabilities 379,768 367,510 Long-term debt 669,614 730,623 Long-term lease liabilities 20,028 22,937 Deferred tax liabilities 138,828 146,957 Non-current accrued pension and postretirement benefits 23,783 29,457 Other non-current liabilities 24,445 31,805 Total liabilities 1,256,466 1,329,289 Equity Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2024 –  17,673,607 shares; 2023 – 17,991,988 shares 17,674 17,992 Capital in excess of par value 903,781 940,101 Retained earnings 633,731 550,641 Accumulated other comprehensive loss (201,619) (124,415) Total Quaker shareholders' equity 1,353,567 1,384,319 Noncontrolling interest 616 603 Total equity 1,354,183 1,384,922 Total liabilities and equity $      2,610,649 $      2,714,211 QUAKER CHEMICAL CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited; Dollars in thousands) Year Ended December 31, 2024 2023 Cash flows from operating activities Net income $         116,729 $         112,872 Adjustments to reconcile net income to net cash provided by operating activities: Amortization of debt issuance costs 1,413 1,413 Depreciation and amortization 84,119 81,987 Equity in undistributed earnings of associated companies, net of dividends (2,733) (11,149) Deferred income taxes (10,033) (11,442) Uncertain tax positions (non-deferred portion) (2,372) (644) Deferred compensation and other, net 4,867 5,711 Share-based compensation 14,991 14,605 Gain on disposal of property, plant, equipment and other assets (810) (1,307) Restructuring and related charges 6,530 7,588 Pension and other postretirement benefits (4,460) (2,079) Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions: Accounts receivable 24,975 32,169 Inventories (3,244) 49,751 Prepaid expenses and other current assets (6,242) (21) Accrued restructuring (7,595) (9,786) Accounts payable and accrued liabilities (8,637) 5,937 Estimated taxes on income (2,920) 3,415 Net cash provided by operating activities 204,578 279,020 Cash flows from investing activities Investments in property, plant and equipment (41,794) (38,800) Payments related to acquisitions, net of cash acquired (39,302) — Proceeds from disposition of assets 4,676 11,179 Net cash used in investing activities (76,420) (27,621) Cash flows from financing activities Payments of long-term debt (57,221) (38,932) Borrowings (payments) on revolving credit facilities, net 17,916 (164,769) Borrowings (payments) on other debt, net 1,441 (506) Dividends paid (33,170) (31,650) Shares purchased under share repurchase program (49,247) — Other stock related activity (2,383) (2,749) Net cash (used in) provided by financing activities (122,664) (238,606) Effect of foreign exchange rate changes on cash (11,141) 771 Net (decrease) increase in cash and cash equivalents (5,647) 13,564 Cash and cash equivalents at the beginning of the period 194,527 180,963 Cash and cash equivalents at the end of the period $         188,880 $         194,527 SOURCE Quaker Chemical Corporation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News